Related Experiment Videos

Age-related acute adriamycin cardiotoxicity in mice

M Matsumura1, K Nishioka, T Fujii

  • 1Department of Pediatrics (Cardiology), Kyoto University Hospital, Japan.

Insights

Adriamycin is less toxic to infant mouse heart mitochondria than adult mouse heart mitochondria. This study compared myocardial mitochondrial function after adriamycin exposure in infant and adult mice.

Area of Science:

  • Biochemistry
  • Cardiovascular Science
  • Toxicology

Background:

  • Adriamycin (doxorubicin) is a widely used chemotherapy agent.
  • Cardiotoxicity is a significant dose-limiting side effect of adriamycin treatment.
  • Age-dependent differences in adriamycin toxicity are not fully understood.

Purpose of the Study:

  • To compare the effects of acute adriamycin exposure on myocardial mitochondrial function in infant and adult mice.
  • To investigate age-related differences in adriamycin-induced mitochondrial dysfunction.

Main Methods:

  • Mice (infant and adult) received intraperitoneal injections of adriamycin or saline.
  • Heart mitochondria were isolated 48 hours post-injection.
  • Mitochondrial function was assessed by measuring oxygen consumption (state 3 respiration) and respiratory control ratio (RCR).
  • Enzyme activities of the respiratory chain (SCCR, NCCR, CCO) and ANT were determined.

Main Results:

  • Serum and heart adriamycin concentrations were similar between infant and adult mice.
  • Adult mice showed significant decreases in state 3 respiration, RCR, SCCR, and NCCR activities after adriamycin exposure.
  • Infant mice exhibited no significant changes in these parameters following adriamycin administration.
  • No significant changes in CCO and ANT enzyme activities were observed in either age group.

Conclusions:

  • Adriamycin significantly impairs myocardial mitochondrial function in adult mice.
  • Infant mice demonstrate greater resistance to adriamycin-induced myocardial mitochondrial toxicity compared to adult mice.
  • Age is a critical factor influencing adriamycin cardiotoxicity at the mitochondrial level.

Related Concept Videos